| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Alogliptin Benzoate | (R)-2-((3-Methyl-2, 4-dioxo-6-(piperidin-3-ylamino)-3, 4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile | VE0010128 | View |
Alogliptin Benzoate Related Compound
Alogliptin benzoate regulates blood sugar levels by increasing the production of hormones that cause the pancreas to produce more insulin.
References
- Rendell, Marc, et al. “Alogliptin Benzoate for the Treatment of Type 2 Diabetes.” Expert Opinion on Pharmacotherapy, vol. 13, no. 4, Feb. 2012, pp. 553–63, https://doi.org/10.1517/14656566.2012.656088. Accessed 9 Feb. 2023.
- Kishimoto, Shinji, et al. “Effects of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin on Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus.” American Journal of Hypertension, vol. 32, no. 7, May 2019, pp. 695–702, https://doi.org/10.1093/ajh/hpz065. Accessed 9 Feb. 2023.
- PubChem. “Alogliptin.” @Pubchem, PubChem, 2023, pubchem.ncbi.nlm.nih.gov/compound/Alogliptin. Accessed 9 Feb. 2023.
FAQ’s
What is alogliptin benzoate?
Alogliptin benzoate is a benzoate salt formed by the equimolar combination of alogliptin and benzoic acid. It is used to treat type 2 diabetes. It functions as a dipeptidyl-peptidase IV inhibitor and a hypoglycemic agent.
Does alogliptin benzoate raise blood pressure?
Alogliptin was linked to improvements in not just glucose metabolism but also blood pressure and arterial stiffness in hypertensive T2DM patients. The baPWV cut-off value may allow for the identification of alogliptin responders in hypertensive individuals with T2DM.
How many different Alogliptin benzoate formulation are there?
Alogliptin benzoate is available in tablets and capsule
